Acasti pharma investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of acasti pharma inc. - acst

New orleans--(business wire)--former attorney general of louisiana charles c. foti, jr., esq. and the law firm of kahn swick & foti, llc (“ksf”) are investigating the proposed merger of acasti pharma inc. (“acasti” or the “company”) (nasdaqgs: acst) with grace therapeutics inc., pursuant to which acasti shareholders will end up owning only approximately 55% of the combined company. ksf is seeking to determine whether the merger and the process that led to it are adequate, or whether the mer
ACST Ratings Summary
ACST Quant Ranking